Charles R. Wood Cancer Center at Glens Falls Hospital — Glens Falls, New York

Charles R. Wood Cancer Center at Glens Falls Hospital is a clinical research site located in Glens Falls, New York, United States 12801.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Charles R. Wood Cancer Center at Glens Falls Hospital has participated in 37 clinical trials with 2 currently active.

Therapeutic areas: Lymphoma, Lung Cancer, Anemia.

Sponsors: Alliance for Clinical Trials in Oncology, NSABP Foundation Inc, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glens Falls

Browse all research sites in New York · View every site in Glens Falls

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charles R. Wood Cancer Center at Glens Falls Hospital?

Charles R. Wood Cancer Center at Glens Falls Hospital has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charles R. Wood Cancer Center at Glens Falls Hospital conducted?

Charles R. Wood Cancer Center at Glens Falls Hospital has 37 clinical trials on record, with 2 currently active. Their work covers Lymphoma, Lung Cancer, Anemia.

Is Charles R. Wood Cancer Center at Glens Falls Hospital accredited by Crixeo Clinical Trials?

Charles R. Wood Cancer Center at Glens Falls Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charles R. Wood Cancer Center at Glens Falls Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.